StockTipsArenaBeta

BUY Divi's Laboratories Limited — Manas Jaiswal

BUYDivi's Laboratories Limited

byManas JaiswalHorizon: NA (inferred Swing (≤2wk))23 Sept 2026via CNBC Awaaz.

Entry₹9,540.5Inferred
Target₹9,900
Total upside +3.77%
Stop loss₹9,450-0.95% risk
CMP₹9,614.5Just now
Active+0.78%+2.97%upside left 14d left
Follow Manas Jaiswal for new calls(32% target hit, 319 closed calls)Get alertsWatch DIVISLAB for new buy/sell callsGet alertsSee 252 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 24 Sept, 10:40 am IST
2 supporting2 neutral1 opposing
Supports the BUY call (2)

Divi's Laboratories posts 65% PAT surge in Q1FY27 on strong revenue growth

NewsGoogle News·15 Sept · 1w ago

(opens in new tab)

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·26 Aug · 4w ago

Neutral / worth noting (2)

Divi's Laboratories (DIVISLAB.NS) Steadies Near ₹9,410 as Pharma Major Holds Above Key Support - Catalyst Driven Stocks

NewsGoogle News·22 Sept · 2d ago

(opens in new tab)

2 quiet pharma stocks are making very different cash bets. Add to watchlist?

NewsGoogle News·15 Sept · 1w ago

(opens in new tab)
Weighs against the BUY call (1)

MACD below its signal line — bearish momentum

Technicals · macd·24 Sept · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.